Company
ENDRA Life Sciences Inc (NASDAQ: NDRA): Stock Forecast For 2025 Remains Weak With A Downward Revision Of 35.3%
In the last trading session, 4.04 million shares of the ENDRA Life Sciences Inc (NASDAQ:NDRA) were traded, and its beta was -0.21. Most recently the